Skip to main content
Earnings Labs
Relmada Therapeutics, Inc. logo

Relmada Therapeutics, Inc. (RLMD) Earnings

NASDAQ·Healthcare·Biotechnology

$6.89

+5.11%

Mkt Cap $487.67M

EPS — Estimate vs Actual

Mkt Cap

$487.67M

P/E

Fwd P/E

P/S

Rev TTM

EPS TTM

-$1.11